Hikma Pharmaceuticals Share News (HIK)

LONDON MARKET CLOSE: Stocks Mixed Amid Puzzling Greek Offer Exchange

WINNERS & LOSERS: Tesco And Sainsbury's Beaten By Morrisons

TOP NEWS: UK Economic Growth Revised Up In First Quarter

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

PRESS: Hikma, Mallinckrodt Bid For Boehringer Assets - Bloomberg

Boehringer's Roxane Labs draws bid from Hikma, Mallinckrodt- Bloomberg

June 29 (Reuters) - Jordan's Hikma Pharmaceuticals Plc has emerged as a bidder for German drugmaker Boehringer Ingelheim's generics unit Roxane Labs, Bloomberg reported, citing people familiar with the matter. Other bidders for the U.S.-based Boehringer unit include Mallinckrodt Plc and Pe

MEDIA-Hikma, Mallinckrodt said to bid for Boehringer's Roxane Labs - Bloomberg

-- Source link: (http://bloom.bg/1NqCMdX) -- Note: Reuters has not verified this story and does not vouch for its accuracy

Broker tips: GlaxoSmithKline, Astrazeneca, Hikma, Shire, Petrofac, ARM Holdings

HSBC initiated coverage of the European pharmaceuticals, saying the re-rating over the last few years looks set to continue. In terms of UK stocks, it initiated GlaxoSmithKline at 'buy' with a 1,700p price target, and AstraZeneca and Hikma Pharmaceuticals at 'hold' with 4,640p and 1,936p price targe

BROKER RATINGS SUMMARY: Bernstein Cuts ARM Holdings To Underperform

HSBC initiates coverage of European pharmaceuticals Astra, GSK, Hikma and Shire

HSBC initiated coverage of the European pharmaceuticals, saying the re-rating over the last few years looks set to continue. Although some pharma companies, such as AstraZeneca, still face generic pressure for drugs that contribute significantly to their top and bottom lines, the majority are largel

London close: Stocks finish flat as optimism fades, Greek uncertainty persists

UK stocks erased gains by the close on Friday with investors turning cautious ahead of the weekend, as ongoing uncertainty in Greece eroded earlier optimism. The FTSE 100 finished just 2.57 points higher (+0.04%) at 6,710.45, pulling back after hitting a high of 6,759.29 early on. Markets had opene

LONDON MARKET CLOSE: Shares Flat As ECB Gives Greece Assistance

FTSE 100 movers: Hikma surges on upgrade, miners retreat

UK stocks inched higher on Friday, despite an underwhelming outcome to the Eurogroup's meeting on Greece, with Hikma and Ashteadin the lead after broker upgrades. As of 15:00 BST, the FTSE 100 was trading 0.1% higher at 6,714. Pharmaceuticals group Hikma was a high riser after analysts at Citigroup

Broker tips: BP, Hikma, Kingfisher, Berkeley Group, PZ Cussons

RBC Capital Markets downgraded BP to' sector perform' from 'outperform' and kept the price target at 500p, following the stock's significant outperformance versus its closest peer Royal Dutch Shell. "We continue to see potential upside to BP's cost reduction potential, but feel the risk reward oppor

London midday: Hikma, COLT lead stocks higher despite Greek negativity

UK stocks advanced on Friday as investors shrugged off a disappointing end to the Eurogroup meeting on Greece, and instead sought out bargains following the recent sell-off. The FTSE 100, which dropped to levels not seen since January earlier in the week, was trading up 0.54% at 6,744.20 by midday.